Key insights and market outlook
PT Indomobil Multi Jasa Tbk (IMJS) has injected Rp 499.28 billion into its subsidiary PT CSM Corporatama. The capital injection comes from the proceeds of the Limited Public Offering IV (PUT IV) with pre-emptive rights, supporting the subsidiary's business activities and operational funding.
PT Indomobil Multi Jasa Tbk (IMJS), a listed company on the Indonesia Stock Exchange, has made a significant capital injection of Rp 499.28 billion into its subsidiary PT CSM Corporatama. This substantial investment demonstrates IMJS's commitment to supporting its subsidiary's business expansion and operational requirements.
The capital injection was funded entirely from the proceeds of the Limited Public Offering IV (PUT IV) with pre-emptive rights conducted by IMJS. This strategic use of funds aligns with the company's previously announced plans for utilizing the capital raised from the offering.
The injection of funds into PT CSM Corporatama is expected to enhance the subsidiary's operational capabilities and support its business growth initiatives. This move is part of IMJS's broader strategy to optimize its corporate structure and strengthen its market position through targeted investments in its subsidiaries.
According to Syafitri Meitasari, Corporate Secretary of IMJS, the capital injection was made in accordance with the company's plans to utilize funds raised from the PUT IV HMETD. The decision underscores IMJS's commitment to leveraging its financial resources to drive business growth and create value for its stakeholders.
Capital Injection into Subsidiary
Limited Public Offering Utilization